Jan 2024 Articles

Articles
Effect of Intensive Lifestyle Intervention on Cardiovascular Risk Factors: Analysis From the Perspective of Long-Term Variability
He L, Liu M, Zhuang X, et al.
Journal:
J Am Heart Assoc

First published: January 31, 2024 DOI: 10.1161/JAHA.123.030132
View
- Share
Articles
LDL-C-Lowering Therapies for Adults and Children With Homozygous Familial Hypercholesterolemia: Challenges and Successes
Santos RD, Cuchel M
Journal:
Circulation

First published: January 29, 2024 DOI: 10.1161/CIRCULATIONAHA.123.067241
View
- Share
Articles
Obesity and atherosclerotic cardiovascular disease in adults with heterozygous familial hypercholesterolemia: An analysis from HELLAS-FH registry
Barkas F, Rizos CV, Liamis G, et al.
Journal:
J Clin Lipidol

First published: January 24, 2024 DOI: 10.1016/j.jacl.2024.01.005
View
- Share
Articles
Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis
Björnson E, Adiels M, Taskinen MR, et al.
Journal:
J Am Coll Cardiol

First published: January 23, 2024 DOI: 10.1016/j.jacc.2023.10.039
View
- Share
Articles
Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial
Sayah N, Bhatt DL, Miller M, et al.
Journal:
Eur Heart J

First published: January 22, 2024 DOI: 10.1093/eurheartj/ehad889
View
- Share
Articles
World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease: 2023 Update
Laranjo L, Lanas F, Sun MC, et al.
Journal:
Glob Heart

First published: January 22, 2024 DOI: 10.5334/gh.1278
View
- Share
Articles
Trends in prevalence, risk factor control and medications in atherosclerotic cardiovascular disease among US Adults, 1999-2018
Zhang X, Chen Z, Fang A, et al.
Journal:
Am J Prev Cardiol

First published: January 20, 2024 DOI: 10.1016/j.ajpc.2024.100634
View
- Share
Articles
Influence of Repeated Plaque Visualization on Cardiovascular Risk Reduction after 3 years; a randomized controlled trial
Whitmore K, Zhou Z, Magnussen CG, et al.
Journal:
Eur J Prev Cardiol

First published: January 19, 2024 DOI: 10.1093/eurjpc/zwae026
View
- Share
Articles
Exposome in ischaemic heart disease: beyond traditional risk factors
Montone RA, Camilli M, Calvieri C, et al.
Journal:
Eur Heart J

First published: January 18, 2024 DOI: 10.1093/eurheartj/ehae001
View
- Share
Articles
Aerobic, resistance, or combined exercise training and cardiovascular risk profile in overweight or obese adults: the CardioRACE trial
Lee DC, Brellenthin AG, Lanningham-Foster LM, et al.
Journal:
Eur Heart J

First published: January 17, 2024 DOI: 10.1093/eurheartj/ehad827
View
- Share
Articles
Impact of Bempedoic Acid on Total Cardiovascular Events: A Prespecified Analysis of the CLEAR Outcomes Randomized Clinical Trial
Nicholls SJ, Nelson AJ, Lincoff AM, et al.
Journal:
JAMA Cardiol

First published: January 17, 2024 DOI: 10.1001/jamacardio.2023.5155
View
- Share
Articles
Efficacy and safety of bempedoic acid in patients with heterozygous familial hypercholesterolemia: analysis of pooled patient-level data from phase 3 clinical trials
Duell PB, Banach M, Catapano AL, et al.
Journal:
J Clin Lipidol

First published: January 11, 2024 DOI: 10.1016/j.jacl.2023.12.005
View
- Share

Jan 2024 Articles

Articles

Effect of Intensive Lifestyle Intervention on Cardiovascular Risk Factors: Analysis From the Perspective of Long-Term Variability

He L, Liu M, Zhuang X, et al.

Articles

LDL-C-Lowering Therapies for Adults and Children With Homozygous Familial Hypercholesterolemia: Challenges and Successes

Santos RD, Cuchel M

Articles

Obesity and atherosclerotic cardiovascular disease in adults with heterozygous familial hypercholesterolemia: An analysis from HELLAS-FH registry

Barkas F, Rizos CV, Liamis G, et al.

Articles

Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis

Björnson E, Adiels M, Taskinen MR, et al.

Articles

Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial

Sayah N, Bhatt DL, Miller M, et al.

Articles

World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease: 2023 Update

Laranjo L, Lanas F, Sun MC, et al.

Articles

Trends in prevalence, risk factor control and medications in atherosclerotic cardiovascular disease among US Adults, 1999-2018

Zhang X, Chen Z, Fang A, et al.

Articles

Influence of Repeated Plaque Visualization on Cardiovascular Risk Reduction after 3 years; a randomized controlled trial

Whitmore K, Zhou Z, Magnussen CG, et al.

Articles

Exposome in ischaemic heart disease: beyond traditional risk factors

Montone RA, Camilli M, Calvieri C, et al.

Articles

Aerobic, resistance, or combined exercise training and cardiovascular risk profile in overweight or obese adults: the CardioRACE trial

Lee DC, Brellenthin AG, Lanningham-Foster LM, et al.

Articles

Impact of Bempedoic Acid on Total Cardiovascular Events: A Prespecified Analysis of the CLEAR Outcomes Randomized Clinical Trial

Nicholls SJ, Nelson AJ, Lincoff AM, et al.

Articles

Efficacy and safety of bempedoic acid in patients with heterozygous familial hypercholesterolemia: analysis of pooled patient-level data from phase 3 clinical trials

Duell PB, Banach M, Catapano AL, et al.

Articles

Effect of Intensive Lifestyle Intervention on Cardiovascular Risk Factors: Analysis From the Perspective of Long-Term Variability

He L, Liu M, Zhuang X, et al.

Share

Articles

LDL-C-Lowering Therapies for Adults and Children With Homozygous Familial Hypercholesterolemia: Challenges and Successes

Santos RD, Cuchel M

Share

Articles

Obesity and atherosclerotic cardiovascular disease in adults with heterozygous familial hypercholesterolemia: An analysis from HELLAS-FH registry

Barkas F, Rizos CV, Liamis G, et al.

Share

Articles

Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis

Björnson E, Adiels M, Taskinen MR, et al.

Share

Articles

Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial

Sayah N, Bhatt DL, Miller M, et al.

Share

Articles

World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease: 2023 Update

Laranjo L, Lanas F, Sun MC, et al.

Share

Articles

Trends in prevalence, risk factor control and medications in atherosclerotic cardiovascular disease among US Adults, 1999-2018

Zhang X, Chen Z, Fang A, et al.

Share

Articles

Influence of Repeated Plaque Visualization on Cardiovascular Risk Reduction after 3 years; a randomized controlled trial

Whitmore K, Zhou Z, Magnussen CG, et al.

Share

Articles

Exposome in ischaemic heart disease: beyond traditional risk factors

Montone RA, Camilli M, Calvieri C, et al.

Share

Articles

Aerobic, resistance, or combined exercise training and cardiovascular risk profile in overweight or obese adults: the CardioRACE trial

Lee DC, Brellenthin AG, Lanningham-Foster LM, et al.

Share

Articles

Impact of Bempedoic Acid on Total Cardiovascular Events: A Prespecified Analysis of the CLEAR Outcomes Randomized Clinical Trial

Nicholls SJ, Nelson AJ, Lincoff AM, et al.

Share

Articles

Efficacy and safety of bempedoic acid in patients with heterozygous familial hypercholesterolemia: analysis of pooled patient-level data from phase 3 clinical trials

Duell PB, Banach M, Catapano AL, et al.

Share